Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00392691
Status:
COMPLETED
Last Update Posted:
2019-05-15
First Post:
2006-10-25
Brief Title:
Melphalan Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkins Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Sponsor:
Swiss Group for Clinical Cancer Research
Organization:
Swiss Group for Clinical Cancer Research
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10
Start Date Type:
None
Primary Completion Date:
2012-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-25
First Submit QC Date:
October 25 2006
Study First Post Date:
2006-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-13
Last Update Post Date:
2019-05-15
Last Update Post Date Type:
ACTUAL